Smart Money · Holder IQ
84.7 / 100
Tracked high-scoring holders are adding shares.
COAG
Hemab Therapeutics Holdings, Inc. Common StockNASDAQ
Healthcare • Biotechnology
$42.81-12.67%
Close Nov 9, 2026
- Market cap
- $2B
- 1 month
- +35.4%
- 3 months
- -17.3%
- 1 year
- —
- Dividend
- No dividends on record
- EPS estimate, results pending
- -$0.52Quarter ended Sep 30, 2026 · 5 analysts · -1.0% in 30d
- Short interest
- 15.6% of float3.2M shares · settled Oct 15, 2026 · -6.8% since Sep 30, 2026 · FINRA
Reading stored signals…
Estimate history · same fiscal quarter
Quarter ended Sep 30, 2026. Source: EODHD earnings_trend.
| Observed / analysts | EPS | Revenue |
|---|---|---|
| 5 analysts | -0.5153 | — |
| 5 analysts | -0.5153 | — |
| 5 analysts | -0.5153 | — |
| 4 analysts | -0.51 | — |
| 4 analysts | -0.51 | — |
Dates identify stored observations, not earnings announcements. Gaps do not mean estimates were unchanged. The analyst group and vendor earnings basis may change.
Link an account to see your stake, watchlist and past holdings. Compare changes in earnings expectations with your investment case. These are analyst estimates, not reported results or a prediction of your return.
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- —
- Free cash flow
- —
- Book value
- $454.27M
- Total debt
- $1.03M
- P/E
- —
- Price / sales
- —
- Price / book
- 4.4×
- FCF yield
- —
- Net margin
- —
EODHD (TTM) · as of Nov 9, 2026
End-of-day close from stored market data, not a live quote.
About Hemab Therapeutics Holdings, Inc. Common Stock
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark.
Read more
Its products includes (HMB-001), is a bispecific antibody currently in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency; and second clinical-stage asset, HMB-002, is a monovalent antibody in Phase 1/2 clinical development for the subcutaneous prophylactic treatment of Von Willebrand disease. It also advances multiple preclinical and discovery-stage assets. The company was founded in 2020 and is based in Cambridge, Massachusetts.
- Website
- hemab.com
- Headquarters
- Cambridge, MA, United States
- Employees
- 59
- Listed
- May 1, 2026
- Fiscal year ends
- December
Company profile from EODHD, stored Oct 27, 2026.
Quarterly results
The last 4 fiscal quarters from EODHD’s latest stored vendor-normalized figures. These may include restatements. Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 11, 2026 | — | — | — | -$26.1M | -$24.2M |
| Mar 2026filed Mar 31, 2026 | — | — | — | -$23.6M | -$22.7M |
| Jun 2025 | — | — | — | -$16.1M | -$12.2M |
| Mar 2025 | — | — | — | -$16.6M | -$15.3M |
Balance sheet · cash, debt and near-term obligations
What resources sit beside the obligations? These are balances at each fiscal quarter end, not cash earned during the quarter. Amounts are in USD, the reporting currency.
As of
- Reported cash
- $237.4M
- Reported total debt
- $1.0M
- Current assets
- $464.0M
- Current liabilities
- $12.9M
Vendor filing date:
As of
- Reported cash
- $49.9M
- Reported total debt
- $1.1M
- Current assets
- $169.4M
- Current liabilities
- $13.2M
Vendor filing date:
As of
- Reported cash
- Unavailable
- Reported total debt
- Unavailable
- Current assets
- Unavailable
- Current liabilities
- Unavailable
A qualified balance sheet is unavailable for this period.
As of
- Reported cash
- Unavailable
- Reported total debt
- Unavailable
- Current assets
- Unavailable
- Current liabilities
- Unavailable
A qualified balance sheet is unavailable for this period.
Link an account to see your stake, watchlist and past holdings. Compare cash and debt across dates when reviewing its reliance on financing. Current assets can include receivables and inventory; current liabilities include bills as well as borrowings. They are not all spendable cash or all debt. These figures alone do not establish the ability to repay.
Source: EODHD’s latest stored vendor-normalized balance sheets, matched to the same security and fiscal end as these income periods. They may include restatements and are not an originally-filed or knowledge-time history. No net debt, coverage ratio or replacement balance is calculated. Read the SEC guide to financial statements for the distinction between balances and cash flows.
Fiscal years · last 1
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Dec 31, 2025 | — | — | — | -$70.1M | -$63.9M |
Annual cash generation
Does profit turn into cash? Compare COAG’s accounting profit with operating cash flow and capital spending. Amounts are in USD.
Fiscal year ending
- Net income
- -$63.9M
- Operating cash flow
- -$61.5M
- Capital spending
- $16.0K
- Free cash flow
- -$61.5M
Link an account to see your stake, watchlist and past holdings. Compare cash generation and investment needs with your thesis. Working capital and non-cash charges can separate profit from cash. Capital spending can reduce free cash flow while earnings rise. For a long or short position, that gap alone does not predict a price move.
Cash-flow source and meaning
Source: EODHD annual financial statements, latest stored vendor-normalized figures. These may include restatements and may differ from the filer’s own XBRL. A filing date is not the knowledge date of this version of the values.
Free cash flow is the vendor’s reported figure, shown only when it agrees with operating cash flow less capital spending recorded as a positive outflow. It is not cash guaranteed for dividends or buybacks, and it does not subtract every financing obligation. Missing or sign-incompatible inputs are not filled in. An unlabelled currency is used only for a confirmed domestic USD filer. These are annual statements, not forecasts or an originally-filed history.
Cash allocation: dividends, shares and debt
Where did COAG’s financing cash go? Compare cash paid as dividends with net share and debt transactions across fiscal years. Amounts are in USD, the reporting currency. These are company-wide totals, not per-share payouts.
Fiscal year ended
Vendor filing date:
- Cash dividends paid
- Unavailable
- Net share issuance / purchases
- Unavailable
- Net borrowing / repayment
- -$120.0K
- Total financing cash flow
- $156.3M
Link an account to see your stake, watchlist and past holdings. Compare these uses of cash with operating cash generation and the debt on the balance sheet. A negative net share movement means purchases exceeded issuance; it does not give gross buybacks. A dividend or share purchase can be financed with borrowing, and none of these flows guarantees a future payment or price return.
Allocation source and sign conventions
Source: EODHD annual cash-flow statements, latest stored vendor-normalized values for the same security and fiscal year. These can include restatements; a filing date is not the knowledge date of this version.
Dividends are positive cash paid out. For net share transactions, net borrowing and total financing, positive means cash in and negative means cash out. Net share transactions combine issuance and purchases; they are not gross repurchases, a change in shares outstanding, or stock compensation. Total financing includes other flows and is not the sum of just these three lines. Missing amounts stay unavailable; zero means a reported zero. No FX conversion, shareholder-return total or forecast is inferred.
Company Quality Grade
How steadily did the business compound its per-share book value with dividends over 40 quarters? This historical measure is not a stock-price return or a forecast.
No published 40-quarter grade for this issuer. This is not a zero or a poor-quality verdict.
Link an account to see your stake, watchlist and past holdings. Use this to question the durability of the business behind your investment case, alongside its filings and valuation. A withheld grade is a data or method limit, not a sell signal. For a short position, it does not predict timing, borrowing costs or downside. It does not measure your account’s return.
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched COAG. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
3,161,285 shares short
-228,845 shares (-6.8%) vs Sep 30, 2026
15.6% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
3,390,130 shares short
+749,092 shares (+28.4%) vs Sep 15, 2026
16.7% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,641,038 shares short
+533,040 shares (+25.3%) vs Aug 31, 2026
11.1% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
2,107,998 shares short
+75,310 shares (+3.7%) vs Aug 14, 2026
8.9% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
2,032,688 shares short
-5,374 shares (-0.3%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
2,038,062 shares short
+379,205 shares (+22.9%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind COAG’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
No qualified split events are stored. This does not establish that the stock has never split.
Up to six stored split dates through Nov 10, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Link an account to see your stake, watchlist and past holdings.
We’ll show you if COAG is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: HIGH
19 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Sep 22, 2026
Insider context
Sentiment: unknown
No recent insider trades detected.
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 3
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
56 filers reported a long position in COAG for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
84.1%
of the 36.3M shares 13-F filers reported
Moves vs Q1 2026
No comparable changes
10 new
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | $286.8M · 7.8M shares | 7.8M | New |
| 2 | Novo Holdings A/S | $153.6M · 4.2M shares | 4.2M | New |
| 3 | FMR LLC | $135.8M · 3.7M shares | 3.7M | New |
| 4 | Capital International Investors | $132.4M · 3.6M shares | 3.6M | New |
| 5 | Deep Track Capital, LP | $132.3M · 3.6M shares | 3.6M | New |
| 6 | Siren, L.L.C. | $76.6M · 2.1M shares | 2.1M | New |
| 7 | Avoro Capital Advisors LLC | $70.7M · 1.9M shares | 1.9M | New |
| 8 | Bain Capital Life Sciences Investors, LLC | $60.6M · 1.7M shares | 1.7M | New |
| 9 | JPMorgan Chase & Co | $42.3M · 1.2M shares | 1.2M | New |
| 10 | Vanguard Capital Management LLC | $28.7M · 780.8K shares | 780.8K | New |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of COAG file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Nov 6, 2026 | FMR LLC13G · passive · amended | 10.4% |
| Aug 14, 2026 | Novo Holdings A/S13G · passive | 9% |
| Aug 14, 2026 | Avoro Capital Advisors LLC13G · passive | 7.06% |
| Aug 12, 2026 | Capital International Investors13G · passive | 7.7% |
| Aug 7, 2026 | Invus Global Management LLC13G · passive | 5.1% |
| Aug 5, 2026 | CIK 208659313G · passive | 5.4% |
| May 11, 2026 | Ra Capital Management, L.P.13G · passive | 16.6% |
| May 11, 2026 | Ai Den-Mab LLC13D · activist | 10.4% |
| May 8, 2026 | Deep Track Capital, LP13G · passive | 8.15% |
Moves the factor model did not explain
How much of COAG’s move accompanied the market and its measured style leanings, and how much was left? The residual is unexplained by this fitted model. It does not establish a cause, skill or future alpha.
Return split unavailable. A complete, reconciled model for every market session in this window is unavailable. Missing dates are not filled.
Link an account with dated transactions to see what share of your own holding’s move since its purchase-date close was unexplained, with long and short positions distinguished. Your private holdings never enter this public chart.
Dated model observations (20)
Daily percentage returns, not window contributions. Source: the same dated warehouse rows and model v1.2.0; observed 2026-11-10T10:08:54.395Z. Absent sessions are never interpolated; missing or failed inputs stay unavailable.
| Date | Stock | Market | Styles | Residual |
|---|---|---|---|---|
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable | |
| Unavailable | Unavailable | Unavailable | Unavailable |
How this split is calculated
Each day uses that day’s fitted market intercept and style exposures multiplied by that day’s published factor returns. Their sum plus the independently stored residual must reconcile to the stock return. Window effects are weighted by stock wealth at each day’s start and added; the stock return compounds. Every expected US market session must be present and pass source, identity, model and numerical checks. This retrospective fit is an explanation of measured returns, not evidence of causation or an investable forecast. The window ends at the latest published model session, which can lag the market; today’s unfinished session is excluded.
What insiders reported owning
Reading dated filing evidence…
Get the Full Analysis for COAG
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.